DSS vs MRNA · rev $7.9M vs rev $145.0M
DSS Inc (DSS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
DSS Inc (DSS) is a packaging & containers company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported DSS revenue for 2026-06-30 was $7.9M. Net income was -$10.4M. Revenue was up 83.2% from 2026-03-31 to 2026-06-30. DSS currently screens at market cap $8.3M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
DSS currently screens at market cap $8.3M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DSS and MRNA stock pages for the full models.
Not investment advice.